| Literature DB >> 26740620 |
Karine Robitaille1, Jillian L Rourke2, Joanne E McBane1, Accalia Fu3, Stephen Baird1, Qiujiang Du2, Tatsuya Kin4, A M James Shapiro4, Robert A Screaton5.
Abstract
The expansion of cells for regenerative therapy will require the genetic dissection of complex regulatory mechanisms governing the proliferation of non-transformed human cells. Here, we report the development of a high-throughput RNAi screening strategy specifically for use in primary cells and demonstrate that silencing the cell cycle-dependent kinase inhibitors CDKN2C/p18 or CDKN1A/p21 facilitates cell cycle entry of quiescent adult human pancreatic beta cells. This work identifies p18 and p21 as novel targets for promoting proliferation of human beta cells and demonstrates the promise of functional genetic screens for dissecting therapeutically relevant state changes in primary human cells.Entities:
Keywords: RNA interference (RNAi); beta cell (β-cell); cell cycle; high throughput screening (HTS); pancreatic islet; primary human cells
Mesh:
Substances:
Year: 2016 PMID: 26740620 PMCID: PMC4813485 DOI: 10.1074/jbc.M115.683912
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157